ArticleInvestigative ophthalmology & visual science2026
Archetypal Visual Field Analysis of Patients With Chronic Leber Hereditary Optic Neuropathy in Relation to Visual Recovery.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To use the machine learning algorithm archetypal analysis (AA) to characterize visual field (VF) loss patterns in patients with chronic Leber hereditary optic neuropathy (LHON) and to determine whether these VF patterns differentiate for patients who recovered visual acuity (VA). Methods: For patients with molecularly confirmed LHON, we retrospectively collected 30-2 or 24-2 VFs (Humphrey VF analyzer) performed at least 3 years after disease onset. A total of 220 VFs (220 eyes, 117 patients) were used as input for the AA algorithm. Archetypes (ATs) and relative weights were statistically compared between VA-recovered and not-recovered groups and among primary mitochondrial DNA mutations. K-means clustering and principal component analysis enabled two-dimensional visualization of the relationship among VFs, ATs, mean deviation, and VA. Results: The LHON-AA model consisted of seven ATs: AT1 resembled a total loss VF pattern (30%) and AT2 a normal VF (23%). Small (AT3, 15%) and large (AT4, 10%) central scotomas followed as representative patterns. AT1 was significantly more prevalent in the not-recovered group, whereas AT2 and AT3 predominated in the recovered VA group. Less severe patterns were more present for m.14484T>C/ND6 than the other primary mutations. Two-dimensional visualization highlighted the nonlinear relationship between VA and VF outcome. Conclusions: AA is a robust method for categorizing and quantifying VF damage in patients with chronic LHON, providing novel insights into the complexity of the disease. The findings suggest that the recovery of VA and VF damage are not transposable, although not entirely independent either, and that both parameters should be considered in the comprehensive assessment of functional recovery in LHON.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.